Vertex Inc. (NASDAQ:VERX) (“Vertex” or the “Company”), a global provider of indirect tax technology solutions, reveals that while free, easy product returns are paramount for consumer loyalty, they ...

Vertex reported solid fourth-quarter numbers ... Learn More » However, the "other product revenue" category could start to become more of a factor. Both the Alyftrek CF treatment and Jornavx ...

Goldman Sachs analyst expects positive updates from Vertex's first Investor Day as a public company on March 19, reiterates ...

Vertex's portfolio of CF drugs has fueled earnings performance over the past decade, helping the company grow product revenue to more than $11 billion in the 2024 full year. It's likely these CF drugs ...

Learn more about whether Elastic N.V. or Vertex, Inc. is a better investment based on AAII's A+ Investor grades, which ...

Vertex Impress Aqua is the latest product of Vertex released in November ... Taking connectivity into consideration, the phone has b, g, n, n 5GHz, Dual band, Wi-Fi Hotspot, Wi-Fi Direct with ...

BMO Capital's revised price target suggests a positive outlook for Vertex's financial performance, driven by its latest product offering in the acute pain treatment landscape. With revenue growth ...

Vertex Impress Vira is the latest product of Vertex released in November ... Taking connectivity into consideration, the phone has b, g, n, n 5GHz, Dual band, Wi-Fi Hotspot, Wi-Fi Direct with ...

At a Goldman Sachs event in June, Verve CEO Sekar Kathiresan, M.D., said the Vertex program is “the only product in our pipeline that is liver disease, and we chose to work with them because ...

Goldman Sachs analyst Adam Hotchkiss expressed expectations on Vertex, Inc. (NASDAQ ... investment roadmap and the monetization of new product initiatives. Finally, the analyst expects to know ...